Volume 26, Issue 8 pp. 696-699

Platelet and cardiac function in Darier's disease

S. Tavadia

S. Tavadia

Departments of Dermatology,

Search for more papers by this author
R. C. Tait

R. C. Tait

Haematology and

Search for more papers by this author
T. A. McDonagh

T. A. McDonagh

Cardiology, Royal Infirmary, Glasgow, and

Search for more papers by this author
C. S. Munro

C. S. Munro

Department of Dermatology, Southern General Hospital, Glasgow, UK

Search for more papers by this author
First published: 07 July 2008
Citations: 34
: S. Tavadia, Department of Dermatology, Royal Infirmary, Castle Street, Glasgow, G4 OSF, UK. Tel.: +44 141 2114297. Fax: +44 141 2114663. E-mail: [email protected]

Abstract

ATP2A2, the gene that is abnormal in Darier's disease, encodes SERCA2, a calcium pump that is expressed in many tissues. The wide expression of SERCA2 might suggest that ATP2A2 mutations would cause a multisystem disease. There is however, no evidence of consistent extracutaneous manifestations of Darier's disease. We have conducted preliminary studies in patients with Darier's disease, in two extracutaneous systems in which SERCA2 is known to be important, in order to investigate whether subtle defects have been overlooked. We found no evidence for altered cardiac function in 10 patients using two-dimensional, colour and Doppler echocardiography. There were no consistent defects in platelet function in 12 patients, using bleeding time and aggregation studies. We conclude that the skin is sensitive to defects in SERCA2 function to which other systems appear robust.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.